Start the conversation
Buffett, probably the world's most famous investor, had steered clear of high tech until just the last few years, saying he didn't understand the field.
Kurzweil, on the other hand, has pushed the boundaries of innovation for more than five decades. As a teenager, he created a groundbreaking computer program that could play classical music and netted him an appearance on the TV game show "I've Got a Secret."
He's never turned back, inventing omni-font optical character recognition, flat-bed scanners, text-to-speech programs, and artificial intelligence for trading the markets.
Now, he may be best known for his prediction that in the near future man and machine will become intertwined in an event he calls the "singularity."
Today, I want to tell you why Google is such an intriguing tech investment with enormous upside.
This industry leader has somehow combined Buffett's business genius and Kurzweil's futurist brain…
Google's (Nasdaq: GOOG, GOOGL) Not Standing Pat
As a former part-time musician, I've followed Kurzweil's work for many years now. His Kurzweil K250 synthesizers that debuted in 1984 redefined electronic music.
The sounds from those devices were so realistic that in some tests professionals couldn't tell the difference between a K250 and a real grand piano.
A list of Kurzweil's many inventions would run several paragraphs. When it comes to high tech, few can match his track record.
So, when our favorite futurist took a high-profile Silicon Valley job two years ago, I was excited to see what he might come up with.
Kurzweil has said many times that the three areas most vital to the next phase of human development are what he calls "GNR" – genetics, nanotechnology, and robotics.
I certainly don't disagree with that.
It's not well known, but even before Kurzweil's arrival, the Internet search giant had been making great strides in GNR through its secretive Google X facility.
First, in 2010, came a driverless car. And since then, we've seen Google Glass, glucose-monitoring contact lenses and other biotech projects, Project Wing (drone delivery), and Project Loon (Internet service via high-altitude balloons) come out of the Google X labs.
Wall Street analysts and other investors often criticize Google X's "science fiction-sounding solutions." They claim the company is preoccupied with futuristic technology and doesn't pay enough attention to core search products.
In a recent interview with the Financial Times, Google Chief Executive Officer Larry Page rejected that criticism outright. Page says he emulates none other than Warren Buffett, whose Berkshire Hathaway Inc. (NYSE: BRK.A) is the most successful conglomerate in history; shares of its Series A stock are currently priced at more than $217,000.
Page says he's on a mission to make Google the Berkshire Hathaway of high tech. He told FT that his "patient capital" approach will pay off handsomely for investors over the long haul – and I concur.
If Google wants to compete with Apple Inc. (Nasdaq: AAPL) and other tech leaders and up-and-comers, there's no way it can stand pat.
With that in mind, I want to let you know more about the fascinating breakthroughs Google is making in Kurzweil's GNR.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.